https://www.globenewswire.com/news-release/2023/06/24/2693972/0/en/Enterin-Presents-Data-Demonstrating-Strong-Benefit-of-ENT-03-on-Body-Weight-Adiposity-and-Blood-Glucose-Vs-Semaglutide-in-a-Diet-Induced-Obesity-Mouse-Model.html
0
0
Enterin Presents Data Demonstrating Strong Benefit of ENT-03 on Body Weight, Adiposity and Blood Glucose Vs. Semaglutide in a Diet Induced Obesity Mouse Model - GlobeNewswire
6/24/23 at 5:00am
Organization
GlobeNewswire
Authors
Enterin Inc.
Details
36 words
Summarize
general Health Conditions Enterin Presents Data Demonstrating Strong Benefit of ENT-03 Blood Glucose Vs. Semaglutide American Diabetes Association
Data presented at the American Diabetes Association 83rd Scientific Sessions......
Create an account or login to join the discussion